| Literature DB >> 25349216 |
Cheng Tan1, Li Zhang1, Xian Cheng1, Xiu-Feng Lin1, Rong-Rong Lu2, Jian-Dong Bao1, Hui-Xin Yu3.
Abstract
Curcumin, traditionally used as food and medicinal purposes, has recently been reported to have protective efficacy against hypoxia. Hypoxia is one of the important reactive factors in tumor metastasis, which is a key problem in clinical thyroid cancer therapy. In present study, we investigate the anti-metastatic effect of curcumin on the K1 papillary thyroid cancer cells as well as its potential mechanisms. The results show that curcumin effectively inhibits hypoxia-induced reactive oxygen species (ROS) upregulation and significantly decreases the mRNA and protein expression levels of hypoxia-inducible factor-1α (HIF-1α) in K1 cells. Curcumin also decreases the DNA binding ability of HIF-1α to hypoxia response element (HRE). Furthermore, curcumin enhances E-cadherin expression, inhibits metalloproteinase-9 (MMP-9) enzyme activity, and weakens K1 cells migration under hypoxic conditions. In summary, these results indicate that curcumin possesses a potent anti-metastatic effect and might be an effective tumoristatic agent for the treatment of aggressive papillary thyroid cancers.Entities:
Keywords: Curcumin; K1 papillary thyroid cancer cell; hypoxia-inducible factor-1α; metastasis
Mesh:
Substances:
Year: 2014 PMID: 25349216 PMCID: PMC4935405 DOI: 10.1177/1535370214555665
Source DB: PubMed Journal: Exp Biol Med (Maywood) ISSN: 1535-3699